FDA last week approved ublituximab-xiiy (Briumvi, TG Therapeutics) for treating adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease,
FDA yesterday released the findings and recommendations of an expert panel that evaluated the agency’s Tobacco Program. The panel assessed the Tobacco Program’s regulatory processes
The Cessation in Pregnancy Incentives Trial phase 3 (CPIT III) concludes that providing financial voucher incentives of £400 is highly effective for increasing smoking cessation
The FDA yesterday issued an emergency use authorization (EUA) for the first over-the-counter molecular test authorized for use with saliva specimens to Aptitude Medical Inc. for their
People who stop using tobacco products, alcohol, and the areca nut reduce their chances of getting oral cancer, concludes the International Agency for Research on